Glipizide And Metformin Hydrochloride
NDC Package 0591-3972-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Glipizide And Metformin Hydrochloride is a . Marketed by Watson Laboratories, Inc., this product is identified by NDC 0591-3972 and is authorized under FDA application ANDA077270.

Identification & Billing

NDC Package Code
0591-3972-01
Package Description
100 TABLET, FILM COATED in 1 BOTTLE
Product Code
0591-3972
11-Digit Billing Format
00591397201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Glipizide And Metformin Hydrochloride
Dosage Form
-

Regulatory & Marketing

Labeler Name
Watson Laboratories, Inc.
FDA Application #
ANDA077270
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-28-2005
End Marketing Date
03-31-2011
Listing Expiration
03-31-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0591-3972-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Glipizide And Metformin Hydrochloride, labeled by Watson Laboratories, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Watson Laboratories, Inc. on October 28, 2005. The current certification is valid through March 31, 2011.

How is this Watson Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00591397201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0591-3972-01
11-Digit CMS (5-4-2)
00591-3972-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.